Pseudomonas Infections  >>  Lipoquin (liposomal ciprofloxacin SR)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lipoquin (liposomal ciprofloxacin SR) / Aradigm
NCT00889967 / 2009-014412-35: Safety and Efficacy Study of Ciprofloxacin for Inhalation in Patients With Non-Cystic Fibrosis Bronchiectasis "ORBIT-1"

Completed
2
95
US, Canada, Europe
Ciprofloxacin for Inhalation, Placebo
Aradigm Corporation
Non-Cystic Fibrosis Bronchiectasis
04/11
06/11

Download Options